{
    "organizations": [],
    "uuid": "9fc3e76f6fc43b1c15617e77a0de22f62d70afb2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-acceleron-receives-fda-fast-track/brief-acceleron-receives-fda-fast-track-designation-for-ace-083-in-facioscapulohumeral-muscular-dystrophy-idUSASC09YIN",
    "ord_in_thread": 0,
    "title": "BRIEF-Acceleron Receives FDA Fast Track Designation For Ace-083 In Facioscapulohumeral Muscular Dystrophy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 11:51 AM / Updated 9 minutes ago BRIEF-Acceleron Receives FDA Fast Track Designation For Ace-083 In Facioscapulohumeral Muscular Dystrophy Reuters Staff 1 Min Read\nMay 1 (Reuters) - Acceleron Pharma Inc:\n* ACCELERON RECEIVES FDA FAST TRACK DESIGNATION FOR ACE-083 IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) Source text for Eikon: Further company coverage:",
    "published": "2018-05-01T14:49:00.000+03:00",
    "crawled": "2018-05-01T15:10:32.037+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "receives",
        "fda",
        "fast",
        "track",
        "designation",
        "facioscapulohumeral",
        "muscular",
        "dystrophy",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "acceleron",
        "pharma",
        "inc",
        "acceleron",
        "receives",
        "fda",
        "fast",
        "track",
        "designation",
        "facioscapulohumeral",
        "muscular",
        "dystrophy",
        "fshd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}